Nurofen-maker Reckitt seeks cure after ‘tough’ year

After a cyber attack and a botched product launch spoiled Reckitt Benckiser’s 2017, a pricing squeeze threatens to make this year almost as tough.

Nurofen-maker Reckitt seeks cure after ‘tough’ year

By Thomas Buckley

After a cyber attack and a botched product launch spoiled Reckitt Benckiser’s 2017, a pricing squeeze threatens to make this year almost as tough.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited